Education
The Art of Teaching Care Aesthetics
For more than 40 years, Dr. Lupo has dedicated her career to a robust cosmetic dermatology practice in New Orleans, as well as teaching and mentoring dermatology residents and fellows. “I’m honored to accept this award because the Foundation is so well-respected and their only agenda is to do good things for people,” Dr. Lupo…
2024 DF Clinical Symposium
The DF Clinical Symposium has a reputation for excellence that attracts hundreds yearly to receive a serious, in-depth medical educational experience and support the Foundation’s work.
Through the Lens of Education
Timothy T. Berger, MD, has always been a visual person and likes the stories art can tell. He understands something in the clinic better when he can draw a picture of it. Dr. Berger was Professor of Clinical Dermatology in the Department of Dermatology at the UCSF School of Medicine and, for his dedication to…
Register by December 22
2024 DF Clinical Symposium in Naples, Florida
The Clinical Symposium’s Continuing Medical Education program has a reputation for excellence.
The Value of Connection
In the 38 years he has mentored residents, lectured on dermatology, and run a clinical practice, Dr. Goldfarb has advocated the value of human connection with patients and residents. He believes it inspires trust, enables learning, creates a reciprocal environment of care, and is the central element to bring to a lecture hall, a clinical research unit, or a patient clinic.
2023 DF Clinical Symposium
The DF Clinical Symposium is the national medical education event that attracts dermatologists, residents, and non-physician clinicians seeking a serious, in-depth educational experience. In its 20th year, this peer-reviewed continuing medical education program delivers cutting-edge talks from today’s specialty experts on every aspect of dermatology.
Mohs for Melanoma
Dr. Bordeaux’s key takeaway message is that Mohs decreases the local recurrence of melanoma and helps reduce the number of re-excisions that patients undergo due to positive margins
Dermatofibrosarcoma
NCCN recommends Mohs as the first-line therapy for DFSP